Fmr LLC Increases Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Fmr LLC raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 7.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,280,890 shares of the company’s stock after buying an additional 237,888 shares during the period. Fmr LLC’s holdings in Henry Schein were worth $239,177,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Cromwell Holdings LLC boosted its holdings in Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the period. Studio Investment Management LLC boosted its stake in shares of Henry Schein by 3.8% in the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after buying an additional 172 shares during the period. Simplify Asset Management Inc. grew its position in shares of Henry Schein by 5.0% during the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after buying an additional 175 shares in the last quarter. Sequoia Financial Advisors LLC increased its stake in shares of Henry Schein by 3.2% during the second quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after buying an additional 176 shares during the period. Finally, Mather Group LLC. lifted its stake in Henry Schein by 16.8% in the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after acquiring an additional 216 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on HSIC shares. UBS Group dropped their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Robert W. Baird decreased their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Evercore ISI upped their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Six research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $79.38.

Henry Schein Trading Down 0.8 %

HSIC opened at $77.05 on Monday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The business’s 50 day moving average is $71.48 and its two-hundred day moving average is $69.90. The firm has a market cap of $9.61 billion, a price-to-earnings ratio of 31.71, a price-to-earnings-growth ratio of 2.21 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the company posted $1.32 EPS. On average, research analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.